This content has been reviewed and approved by our team of medical providers
Early Research in Autoimmune Disease & Fibromyalgia What It Shows and Why Its Limited Fibromyalgia: Early Signals, No Conclusions Some observational reports describe symptom improvements (pain, fatigue, opioid use) in people taking GLP-1 medications, but limitations are consistent: non-randomized design, small samples, and confounding from weight loss, sleep, and metabolic improvements
This prior adaptation means you can tolerate a higher starting dose without the full spectrum of GI side effects that a GLP-1 naive person would experience
it will make the agency gun shy in future circumstances," she says
Although originally developed for diabetes management, Semaglutide is gaining more attention for its effect on weight loss
Dose escalation protocols are designed to minimize this in both cases